Your positive controls must fall within ±2 standard deviations of their historical mean Ct, and negative controls must remain completely silent. This is the non-negotiable foundation. To validate a diagnostic run, you also need to verify that the difference between an extraction positive control and a PCR positive control does not drift beyond 3 Ct, and that duplicate extraction controls agree within 2 Ct. These tolerances ensure your result from a patient sample is a true reflection of viral status, not artifact.
Every valid RT-PCR run rests on a triad of control checks: absolute silence in negatives, tight statistical placement of positives, and consistent extraction-to-amplification ratios. Without these hard limits, no amount of sample re-testing can rescue a compromised plate.
The Foundation: Core Control Acceptance Criteria
A run is only as trustworthy as its controls. These criteria act as a real-time audit of your entire workflow—from extraction chemistry to thermal cycling.
Negative Controls Must Show No Amplification
The most basic requirement is zero signal. Both your extraction negative control (water or matrix processed through the full sample prep) and your PCR negative template control (water added directly to the master mix) must yield no Ct value—no detectable fluorescence above threshold, across all cycles.
Even a single false signal in a negative well invalidates the run. A late-cycle blip in an NTC suggests low-level reagent contamination or amplicon carryover. This criterion is absolute. There is no acceptable tolerance for noise in the negative track.
Positive Controls Must Fall Within Statistical Bounds
Your known positive material—whether it’s an extracted viral stock or a validated armored RNA reagent—must land within 2 standard deviations of its established expected mean Ct.
For high-sensitivity assays, target an even tighter window: optimally ±1 Ct. This band accounts for normal lot-to-lot variation and minor instrument noise. A positive control shifting by more than 2 SD signals a systemic problem, such as degraded reagent, incorrect cycler calibration, or a pipetting error. Track these values over time using Levey-Jennings plots to catch downward trends before they spike out of bounds.
Extraction Efficiency and Duplicate Consistency
A positive control that has undergone nucleic acid extraction (the extraction control) should not deviate dramatically from an un-extracted PCR positive control. The difference between the two must remain ≤ 3 Ct, with an optimal target of ≤ 1.5 Ct.
This delta reveals extraction efficiency. A widening gap means you are losing target molecules during lysis, binding, or elution. Run duplicate extraction controls in the same plate. The Ct variation between these paired wells must be < 2 Ct. Wider duplicates point to uneven extraction, inconsistent master mix aliquoting, or poor plate sealing—each a source of imprecision that will blur sample interpretation.
Why These Tolerances Matter: Linking Ct Values to Assay Integrity
Control criteria aren’t just procedural hoops. They are direct surrogates for the quality of every answer you report.
Guarding Against False Negatives
If you acceptance window for a positive control is too wide, you might tolerate a run where extraction efficiency has silently dropped by 5–10%. That moderate drop could push a low-titre clinical sample from a detectable signal into the “negative” zone, producing a dangerous false-negative result. The extraction-to-PCR control delta directly prevents this.
Preventing False Positives
Relaxing the negative control requirement—perhaps by ignoring a single late-cycle NTC signal—invites contamination to masquerade as a true positive. Even when the contamination level seems “low,” it can amplify irregularly and misclassify borderline samples.
Maintaining Quantitative Consistency
In assays that report semi-quantitative viral loads, a 1 Ct shift can represent a 2-fold change in target quantity (assuming optimal efficiency). If your positive control drifts by ±2 Ct, the entire calibration curve is shifting, making patient trending unreliable over time.
Defining Diagnostic Cut-Offs for Sample Interpretation
Control acceptance criteria enable you to set clear, defensible sample classification rules. Without stable controls, your cut-offs become arbitrary.
The Positive, Negative, and Inconclusive Zones
A common framework:
- Ct < 32.0: Definitively positive.
- No Ct: Definitively negative.
- Ct 32.0–50.0: Inconclusive.
The inconclusive zone exists because late-cycle signals can arise from low-level target, non-specific priming, or environmental contamination. Any sample falling in this window must be re-tested in duplicate from the primary specimen. A sample is confirmed positive only if both re-test wells produce closely agreeing Ct values; negative if both remain silent.
Setting Cut-Offs Based on Standard Curves
Your positive/negative threshold should be anchored to the linear dynamic range of the assay. Generate a 10-fold dilution series of quantified target RNA, spanning at least four dilutions. The standard curve must yield an R² > 0.985, a slope between -3.0 and -3.9, and a corresponding PCR efficiency of 80% to 110%. The lower limit of reliable detection—the point where the curve remains linear—often dictates the move from “inconclusive” to “negative.”
Understanding the Trade-offs and Common Pitfalls
High-Titre Controls Mask Subtle Failures
Using a strong positive control (e.g., Ct ~20) may always amplify, giving a false sense of security. A low-titre extraction control targeting a Ct around 30 is far more sensitive to mild extraction inefficiency or partial enzyme inhibition. It will fail visible criteria sooner, serving as an early warning system. Conversely, high-titre controls present a greater risk of aerosol cross-contamination to adjacent wells.
Standard Curve Drift Destroys Quantitative Interpretation
If your standard curve R² drops below 0.985 or efficiency falls outside 80–110%, any Ct-based cut-off becomes suspect. The most common culprits: freeze-thaw degradation of RNA standards, inaccurate pipetting of the dilution series, or a failing optical module on the thermal cycler. Never force-approve a run when the standard curve metrics have degraded. Re-testing is mandatory.
Over-Tight Tolerances Can Cripple Throughput
While targeting a ±1 Ct band for controls is aspirational, requiring it for every single run in a high-throughput lab may generate excessive re-runs from normal stochastic variation. If your control lot history shows a stable CV of 1.5%, a ±2 SD window is statistically sound and pragmatic. Use statistical process control charts to set control limits that match your instrument’s real-world precision.
How to Apply This to Your Validation and Routine Workflow
The right acceptance criteria depend on your diagnostic goal and operational context.
- If your primary focus is maximum clinical sensitivity for low-level infections: Use low-titre extraction controls (Ct ~30), require ≤2 Ct difference between extraction and PCR controls, and enforce a tight ±1 Ct band on positive controls. This minimizes the risk of missing patients with low viral load.
- If your primary focus is routine high-throughput screening where a balanced false-positive rate is critical: Maintain the ±2 SD window for positive controls, require absolute silence in all negatives, and strictly apply the 32–50 Ct inconclusive re-test rule to resolve borderline calls without slowing the overall lab flow.
- If your primary focus is quantitative viral load trending over time: Mandate a valid standard curve (R² >0.985, efficiency 90–110%) with every run, and track your positive control Levey-Jennings plot for drift. Reject any run where the standard curve metrics fail, even if individual controls appear in range.
Every criterion you enforce is a statement about the confidence you need in each reported result—decide them with intentionality, and your diagnostic system will become a consistently reliable instrument of truth.
Summary Table:
| Control / Metric | Acceptance Criteria & Ct Tolerance | Key Diagnostic Impact |
|---|---|---|
| Negative Controls (NTC/NEC) | Zero signal / No amplification across all cycles | Prevents false positives & amplicon contamination |
| Positive Controls | ±2 SD of historical mean Ct (optimally ±1 Ct) | Prevents false negatives & detects reagent degradation |
| Extraction vs. PCR Control Delta | ≤ 3 Ct difference (optimally ≤ 1.5 Ct) | Verifies extraction efficiency & target recovery |
| Duplicate Extractions | Delta Ct < 2 Ct between replicate wells | Assures pipetting accuracy & workflow precision |
| Standard Curve Metrics | R² > 0.985, Efficiency 80%–110% (Slope -3.0 to -3.9) | Guarantees reliable viral load quantification |
Establishing robust RT-PCR acceptance criteria requires optimized reagents and dependable quality standards. CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to IVD raw materials, technical services, and consulting—covering every stage from concept to clinic.
Ready to enhance your assay accuracy and streamline diagnostic run validation? Contact us today to speak with our IVD specialists!